Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Macular disease in an elderly population.

D Pauleikhoff1, R P Wormald, L Wright

  • 1University Eye Hospital, Essen, Federal Republic of Germany.

German Journal of Ophthalmology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why the macula?

Eye (London, England)·2017
Same author

Ophthalmologists' perspective.

Methods in molecular medicine·2011
Same author

[Unilateral blurred vision associated with combined macular and papillary edema: a 34-year-old male patient].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2010
Same author

Conflict monitoring in early frontotemporal dementia.

Neurology·2009
Same author

Functional aspects of drusen regression in age-related macular degeneration.

The British journal of ophthalmology·2009
Same author

Characterisation of the macular dystrophy in patients with the A3243G mitochondrial DNA point mutation with fundus autofluorescence.

The British journal of ophthalmology·2008

Age-related macular changes affect 25% of individuals over 65. Macular disease causing vision loss impacts 2.8%, with age being the sole identified risk factor.

Area of Science:

  • Ophthalmology
  • Gerontology
  • Public Health

Background:

  • Macular diseases are a significant cause of vision impairment in the elderly.
  • Accurate prevalence data is crucial for healthcare planning and interpreting clinical findings.

Purpose of the Study:

  • To determine the prevalence of macular diseases in an elderly London population.
  • To identify risk factors associated with age-related macular changes.
  • To establish a baseline for understanding hospital-based data.

Main Methods:

  • A clinical study involving 430 participants aged 65 and above from the general population in London.
  • Clinical examination to assess for degenerative age-related macular changes and lesions causing visual acuity loss.

Related Experiment Videos

Main Results:

  • Approximately 25% of participants exhibited clinically visible degenerative age-related macular changes.
  • 2.8% of the population had macular lesions resulting in visual acuity loss.
  • Age was the only identified risk factor; no correlation with hypertension, smoking, or diabetes was found.
  • Symmetry in drusen characteristics (number, size, density, fluorescence) was observed between eyes.

Conclusions:

  • The study provides essential prevalence data for macular diseases in the elderly population.
  • Age is a key determinant for age-related macular changes.
  • Findings can inform healthcare strategies and the interpretation of clinical data for macular diseases.